EpiPen Gets First Generic Rival After Furor Over High Price

(Bloomberg) -- EpiPen, a life-saving allergy treatment widely criticized for its high price tag, will get generic competition for the first time since the autoinjector was approved more than two de...

Bloomberg Quint

Add BloombergQuint App to Home screen.